Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial

Current affiliations: Thompson Cancer Survival Center, Knoxville, Tennessee; Columbia-Presbyterian Hospital, New York, New York; Mayo Clinic, Rochester, Minnesota; Johns Hopkins Hospital, Baltimore, Maryland; Parkland Memorial Hospital, Dallas, Texas; Washington State University Hospital, Seattle, Washington; Cleveland Clinic Foundation, Cleveland, Ohio; GI Pathology Partners, Memphis, Tennessee, USA; University of Alberta, Edmonton, Alberta; Axcan Pharma Inc, Mont-Saint-Hilaire, Quebec, Canada

Received 24 November 2004; accepted 13 June 2005.

Toronto, Ontario; Vancouver, British Columbia, Canada; Lille, France; Gloucester, Liverpool, UK; Atlanta, Georgia; Baltimore, Maryland; Boston, Massachusetts; Buffalo, New York; Burlington, Vermont; Chicago, Illinois; Cleveland, Ohio; Dallas, Texas; Durham, North Carolina; Houston, Texas; Indianapolis, Indiana; Knoxville, Tennessee; Louisville, Kentucky; New York, New York; Orange, California; Philadelphia, Pennsylvania; Pittsburgh, Pennsylvania; Richmond, Virginia; Rochester, Minnesota; Salt Lake City, Utah; Sarasota, Florida; Seattle, Washington; Valhalla, New York, USA

• Abstract
• Full Text
• PDF
• Images
• References